Proposed use: Ulcerative colitis Proposed forms: Oral capsules, nasal spray, injections, transdermal cream, rectal suppository Proposed use: Wound healing Proposed forms: Subcutaneous or intramuscular injection Secret To Weight Loss May Be Hiding In Your Gut, New Study Suggests Proposed use: Wound healing and inflammatory condition Proposed forms: Cream and gel Proposed use: Obesity and osteoporosis Proposed forms: Subcutaneous injection Proposed use: Cerebral ischemia (shortage of blood flow and oxygen to the brain), migraine and trigeminal neuralgia (chronic pain condition in the face) Proposed form: Intranasal spray, subcutaneous injection Click Here To Sign Up For Our Health Newsletter Proposed use: Opioid withdrawal, chronic insomnia, narcolepsy Proposed form: Subcutaneous injection Proposed use: Insomnia Proposed form: Subcutaneous injection Performance medicine and peptide expert Dr
This testing confirms accurate peptide concentration for both compounds every time
The recommended approach is to discontinue semaglutide, allow a washout period of at least 2-3 weeks (given semaglutide approximately one-week half-life), and then begin retatrutide titration from the standard 1 mg starting dose
Finally, and as a consequence of the above, DPP-4 inhibitors can exert their clinical effects even in advanced stages of type 2 diabetes
2025 Jan 8;17(1):14
& Schneider, F